Skip to content
10-Q

Quarterly Report

AYTU BIOPHARMA, INC AYTU

0001437749-26-002804

← back to feed
Filed
Feb 3, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · Jan 31, 2026 10.73M sh
Shares Diluted Q2 2026 · Dec 31, 2025 10.04M sh
Shares Diluted Q2 2026 · Dec 31, 2025 9.74M sh
Shares Diluted Q2 2026 · Dec 31, 2024 8.49M sh
Shares Diluted Q2 2026 · Dec 31, 2024 8.78M sh
Capex Q2 2026 · Dec 31, 2025 $17K
Capex Q2 2026 · Dec 31, 2024 $142K
Operating Cash Flow Q2 2026 · Dec 31, 2025 $3.06M
Operating Cash Flow Q2 2026 · Dec 31, 2024 $1.72M
Long Term Debt Q2 2026 · Dec 31, 2025 $10M
Cash And Equivalents Q2 2026 · Dec 31, 2025 $30.03M
Cash And Equivalents Q2 2026 · Jun 30, 2025 $30.95M
Stockholders Equity Q2 2026 · Dec 31, 2025 $14.2M
Stockholders Equity Q2 2026 · Sep 30, 2025 $23.17M
Stockholders Equity Q2 2026 · Jun 30, 2025 $18.97M
Stockholders Equity Q2 2026 · Dec 31, 2024 $30.77M
Stockholders Equity Q2 2026 · Sep 30, 2024 $29.83M
Stockholders Equity Q2 2026 · Jun 30, 2024 $27.72M
Current Liabilities Q2 2026 · Dec 31, 2025 $65.56M
Current Liabilities Q2 2026 · Jun 30, 2025 $63.06M
Current Assets Q2 2026 · Dec 31, 2025 $76.24M
Current Assets Q2 2026 · Jun 30, 2025 $79.18M
Total Assets Q2 2026 · Dec 31, 2025 $122M
Total Assets Q2 2026 · Jun 30, 2025 $124.18M
Eps Diluted Q2 2026 · Dec 31, 2025 −$1.05
Eps Diluted Q2 2026 · Dec 31, 2025 −$0.89
Eps Diluted Q2 2026 · Dec 31, 2024 −$0.26
Eps Diluted Q2 2026 · Dec 31, 2024 −$0.41
Eps Basic Q2 2026 · Dec 31, 2025 −$1.05
Eps Basic Q2 2026 · Dec 31, 2025 −$0.89
Eps Basic Q2 2026 · Dec 31, 2024 $0.13
Eps Basic Q2 2026 · Dec 31, 2024 $0.37
Rd Expense Q2 2026 · Dec 31, 2025 $0
Rd Expense Q2 2026 · Dec 31, 2025 $0
Rd Expense Q2 2026 · Dec 31, 2024 $522K
Rd Expense Q2 2026 · Dec 31, 2024 $948K
Net Income Q2 2026 · Dec 31, 2025 −$10.58M
Net Income Q2 2026 · Dec 31, 2025 −$8.62M
Net Income Q2 2026 · Sep 30, 2025 $1.97M
Net Income Q2 2026 · Dec 31, 2024 $788K
Net Income Q2 2026 · Dec 31, 2024 $2.26M
Net Income Q2 2026 · Sep 30, 2024 $1.47M
Operating Income Q2 2026 · Dec 31, 2025 −$1.97M
Operating Income Q2 2026 · Dec 31, 2025 −$3.47M
Operating Income Q2 2026 · Dec 31, 2024 −$1.7M
Operating Income Q2 2026 · Dec 31, 2024 −$2.63M
Gross Profit Q2 2026 · Dec 31, 2025 $9.62M
Gross Profit Q2 2026 · Dec 31, 2025 $18.81M
Gross Profit Q2 2026 · Dec 31, 2024 $10.79M
Gross Profit Q2 2026 · Dec 31, 2024 $22.77M
Revenue Q2 2026 · Dec 31, 2025 $15.17M
Revenue Q2 2026 · Dec 31, 2025 $29.05M
Revenue Q2 2026 · Dec 31, 2024 $16.22M
Revenue Q2 2026 · Dec 31, 2024 $32.8M